Edgewell Q2 adjusted EPS falls to $0.60; GAAP EPS outlook cut to flat-$0.40
Edgewell reported fiscal second-quarter 2026 results, excluding the divested Feminine Care business. Net sales rose 0.6% to $519.5 million, but organic net sales fell 2.4% and adjusted EPS declined to $0.60 from $0.69. The company cut its full-year GAAP EPS outlook to flat to $0.40 from $0.55 to $0.95 because of higher restructuring and legal costs, while keeping its adjusted EPS outlook at $1.70 to $2.10.
Key points
- Q2 net sales $519.5 million, up 0.6%; organic net sales down 2.4%
- GAAP diluted EPS $0.09 vs. $0.43 a year earlier; adjusted EPS $0.60 vs. $0.69
- FY2026 GAAP EPS outlook lowered to flat to $0.40; expected restructuring charges raised to about $90 million from $65 million
- Quarterly dividend of $0.15 per share declared, payable July 9, 2026 to holders of record June 10, 2026
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:58 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 06, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.